{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T12:58:57Z","timestamp":1791464337755,"version":"4.3.4"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,6,4]],"date-time":"2014-06-04T00:00:00Z","timestamp":1401840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2014,6,4]],"date-time":"2014-06-04T00:00:00Z","timestamp":1401840000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/ncomms5029","type":"journal-article","created":{"date-parts":[[2014,6,4]],"date-time":"2014-06-04T07:48:11Z","timestamp":1401868091000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":199,"title":["Structural analysis of atovaquone-inhibited cytochrome bc1 complex reveals the molecular basis of antimalarial drug action"],"prefix":"10.1038","volume":"5","author":[{"given":"Dominic","family":"Birth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Chun","family":"Kao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carola","family":"Hunte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,6,4]]},"reference":[{"key":"BFncomms5029_CR1","doi-asserted-by":"crossref","unstructured":"WHO. World Malaria Report 2012 Fact Sheet, http:\/\/www.who.int\/malaria\/publications\/world_malaria_report_2012\/en\/1\u20132 (2012).","DOI":"10.1155\/2012\/954975"},{"key":"BFncomms5029_CR2","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1016\/j.febslet.2011.04.042","volume":"585","author":"I Petersen","year":"2011","unstructured":"Petersen, I., Eastman, R. & Lanzer, M. Drug-resistant malaria: molecular mechanisms and implications for public health. FEBS Lett. 585, 1551\u20131562 (2011).","journal-title":"FEBS Lett."},{"key":"BFncomms5029_CR3","doi-asserted-by":"crossref","unstructured":"Osei-Akoto, A., Orton, L. C. & Owusu-Ofori, S. Atovaquone-proguanil for treating uncomplicated malaria. Cochrane Database Syst. Rev CD004529 (2005).","DOI":"10.1002\/14651858.CD004529.pub2"},{"key":"BFncomms5029_CR4","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1136\/bmj.a153","volume":"336","author":"DG Lalloo","year":"2008","unstructured":"Lalloo, D. G. & Hill, D. R. Preventing malaria in travellers. BMJ 336, 1362\u20131366 (2008).","journal-title":"BMJ"},{"key":"BFncomms5029_CR5","doi-asserted-by":"publisher","first-page":"e42284","DOI":"10.1371\/journal.pone.0042284","volume":"7","author":"MK Laufer","year":"2012","unstructured":"Laufer, M. K. et al. A longitudinal trial comparing chloroquine as monotherapy or in combination with artesunate, azithromycin or atovaquone-proguanil to treat malaria. PLoS ONE 7, e42284 (2012).","journal-title":"PLoS ONE"},{"key":"BFncomms5029_CR6","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/0169-4758(93)90040-M","volume":"9","author":"AT Hudson","year":"1993","unstructured":"Hudson, A. T. Atovaquone - a novel broad-spectrum anti-infective drug. Parasitol. Today 9, 66\u201368 (1993).","journal-title":"Parasitol. Today"},{"key":"BFncomms5029_CR7","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1128\/AAC.35.2.293","volume":"35","author":"FG Araujo","year":"1991","unstructured":"Araujo, F. G., Huskinson, J. & Remington, J. S. Remarkable in vitro and in vivo activities of the hydroxynaphthoquinone 566C80 against tachyzoites and tissue cysts of Toxoplasma gondii. Antimicrob. Agents Chemother. 35, 293\u2013299 (1991).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFncomms5029_CR8","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.molbiopara.2011.01.002","volume":"177","author":"LM Hughes","year":"2011","unstructured":"Hughes, L. M. et al. Design of anti-parasitic and anti-fungal hydroxy-naphthoquinones that are less susceptible to drug resistance. Mol. Biochem. Parasitol. 177, 12\u201319 (2011).","journal-title":"Mol. Biochem. Parasitol."},{"key":"BFncomms5029_CR9","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/0140-6736(92)92172-C","volume":"340","author":"JA Kovacs","year":"1992","unstructured":"Kovacs, J. A. Efficacy of atovaquone in treatment of toxoplasmosis in patients with AIDS. Lancet 340, 637\u2013638 (1992).","journal-title":"Lancet"},{"key":"BFncomms5029_CR10","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1016\/0006-2952(92)90213-3","volume":"43","author":"M Fry","year":"1992","unstructured":"Fry, M. & Pudney, M. Site of action of the antimalarial hydroxynaphthoquinone, 2-[trans-4-(4\u2032-chlorophenyl) cyclohexyl]-3-hydroxy-1,4-naphthoquinone (566C80). Biochem. Pharmacol. 43, 1545\u20131553 (1992).","journal-title":"Biochem. Pharmacol."},{"key":"BFncomms5029_CR11","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/400_2007_042","volume":"45","author":"C Hunte","year":"2008","unstructured":"Hunte, C., Solmaz, S., Palsdottir, H. & Wenz, T. A structural perspective on mechanism and function of the cytochrome bc 1 complex. Results Probl. Cell. Differ. 45, 253\u2013278 (2008).","journal-title":"Results Probl. Cell. Differ."},{"key":"BFncomms5029_CR12","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.cbpa.2010.05.005","volume":"14","author":"V Barton","year":"2010","unstructured":"Barton, V., Fisher, N., Biagini, G. A., Ward, S. A. & O'Neill, P. M. Inhibiting Plasmodium cytochrome bc1: a complex issue. Curr. Opin. Chem. Biol. 14, 440\u2013446 (2010).","journal-title":"Curr. Opin. Chem. Biol."},{"key":"BFncomms5029_CR13","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/nature05572","volume":"446","author":"HJ Painter","year":"2007","unstructured":"Painter, H. J., Morrisey, J. M., Mather, M. W. & Vaidya, A. B. Specific role of mitochondrial electron transport in blood-stage Plasmodium falciparum. Nature 446, 88\u201391 (2007).","journal-title":"Nature"},{"key":"BFncomms5029_CR14","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1128\/AAC.43.6.1334","volume":"43","author":"IK Srivastava","year":"1999","unstructured":"Srivastava, I. K. & Vaidya, A. B. A mechanism for the synergistic antimalarial action of atovaquone and proguanil. Antimicrob. Agents Chemother. 43, 1334\u20131339 (1999).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFncomms5029_CR15","doi-asserted-by":"publisher","first-page":"3961","DOI":"10.1074\/jbc.272.7.3961","volume":"272","author":"IK Srivastava","year":"1997","unstructured":"Srivastava, I. K., Rottenberg, H. & Vaidya, A. B. Atovaquone, a broad spectrum antiparasitic drug, collapses mitochondrial membrane potential in a malarial parasite. J. Biol. Chem. 272, 3961\u20133966 (1997).","journal-title":"J. Biol. Chem."},{"key":"BFncomms5029_CR16","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/S0969-2126(00)00152-0","volume":"8","author":"C Hunte","year":"2000","unstructured":"Hunte, C., Koepke, J., Lange, C., Rossmanith, T. & Michel, H. Structure at 2.3 angstrom resolution of the cytochrome bc(1) complex from the yeast Saccharomyces cerevisiae co-crystallized with an antibody Fv fragment. Struct. Fold Des. 8, 669\u2013684 (2000).","journal-title":"Struct. Fold Des."},{"key":"BFncomms5029_CR17","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1126\/science.281.5373.64","volume":"281","author":"S Iwata","year":"1998","unstructured":"Iwata, S. et al. Complete structure of the 11-subunit bovine mitochondrial cytochrome bc1 complex. Science 281, 64\u201371 (1998).","journal-title":"Science"},{"key":"BFncomms5029_CR18","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1126\/science.277.5322.60","volume":"277","author":"D Xia","year":"1997","unstructured":"Xia, D. et al. Crystal structure of the cytochrome bc(1) complex from bovine heart mitochondria. Science 277, 60\u201366 (1997).","journal-title":"Science"},{"key":"BFncomms5029_CR19","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/33612","volume":"392","author":"ZL Zhang","year":"1998","unstructured":"Zhang, Z. L. et al. Electron transfer by domain movement in cytochrome bc1. Nature 392, 677\u2013684 (1998).","journal-title":"Nature"},{"key":"BFncomms5029_CR20","unstructured":"Crofts, A. R. inThe Enyzmes of Biological Membranes (ed. Martonosi A. N. 347\u2013382Plenum Publishing Corporation (1985)."},{"key":"BFncomms5029_CR21","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/0022-5193(76)90124-7","volume":"62","author":"P Mitchell","year":"1976","unstructured":"Mitchell, P. Possible molecular mechanisms of the protonmotive function of cytochrome c systems. J. Theor. Biol. 62, 327\u2013367 (1976).","journal-title":"J. Theor. Biol."},{"key":"BFncomms5029_CR22","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.tibs.2005.02.001","volume":"30","author":"A Osyczka","year":"2005","unstructured":"Osyczka, A., Moser, C. C. & Dutton, P. L. Fixing the Q cycle. Trends Biochem. Sci. 30, 176\u2013182 (2005).","journal-title":"Trends Biochem. Sci."},{"key":"BFncomms5029_CR23","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/33612","volume":"392","author":"Z Zhang","year":"1998","unstructured":"Zhang, Z. et al. Electron transfer by domain movement in cytochrome bc1. Nature 392, 677\u2013684 (1998).","journal-title":"Nature"},{"key":"BFncomms5029_CR24","doi-asserted-by":"publisher","first-page":"31303","DOI":"10.1074\/jbc.M302195200","volume":"278","author":"H Palsdottir","year":"2003","unstructured":"Palsdottir, H., Lojero, C. G., Trumpower, B. L. & Hunte, C. Structure of the yeast cytochrome bc1 complex with a hydroxyquinone anion Qo site inhibitor bound. J. Biol. Chem. 278, 31303\u201331311 (2003).","journal-title":"J. Biol. Chem."},{"key":"BFncomms5029_CR25","doi-asserted-by":"publisher","first-page":"31312","DOI":"10.1074\/jbc.M304042200","volume":"278","author":"JJ Kessl","year":"2003","unstructured":"Kessl, J. J. et al. Molecular basis for atovaquone binding to the cytochrome bc1 complex. J. Biol. Chem. 278, 31312\u201331318 (2003).","journal-title":"J. Biol. Chem."},{"key":"BFncomms5029_CR26","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1124\/mol.108.045120","volume":"73","author":"GA Biagini","year":"2008","unstructured":"Biagini, G. A. et al. Acridinediones: selective and potent inhibitors of the malaria parasite mitochondrial bc1 complex. Mol. Pharmacol. 73, 1347\u20131355 (2008).","journal-title":"Mol. Pharmacol."},{"key":"BFncomms5029_CR27","doi-asserted-by":"publisher","first-page":"177ra37","DOI":"10.1126\/scitranslmed.3005029","volume":"5","author":"A Nilsen","year":"2013","unstructured":"Nilsen, A. et al. Quinolone-3-diarylethers: a new class of antimalarial drug. Sci. Transl. Med. 5, 177ra37 (2013).","journal-title":"Sci. Transl. Med."},{"key":"BFncomms5029_CR28","doi-asserted-by":"publisher","first-page":"9042","DOI":"10.1021\/bi060280g","volume":"45","author":"T Wenz","year":"2006","unstructured":"Wenz, T., Hellwig, P., MacMillan, F., Meunier, B. & Hunte, C. Probing the role of E272 in quinol oxidation of mitochondrial complex III. Biochemistry 45, 9042\u20139052 (2006).","journal-title":"Biochemistry"},{"key":"BFncomms5029_CR29","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.pt.2007.08.004","volume":"23","author":"JJ Kessl","year":"2007","unstructured":"Kessl, J. J., Meshnick, S. R. & Trumpower, B. L. Modeling the molecular basis of atovaquone resistance in parasites and pathogenic fungi. Trends Parasitol. 23, 494\u2013501 (2007).","journal-title":"Trends Parasitol."},{"key":"BFncomms5029_CR30","doi-asserted-by":"publisher","first-page":"9731","DOI":"10.1074\/jbc.M111.324319","volume":"287","author":"N Fisher","year":"2012","unstructured":"Fisher, N. et al. Cytochrome b mutation Y268S conferring the atovaquone resistance phenotype in the malaria parasite results in reduced parasite bc1 catalytic turnover and protein expression. J. Biol. Chem. 287, 9731\u20139741 (2012).","journal-title":"J. Biol. Chem."},{"key":"BFncomms5029_CR31","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1093\/jac\/dks504","volume":"68","author":"GL Nixon","year":"2013","unstructured":"Nixon, G. L. et al. Antimalarial pharmacology and therapeutics of atovaquone. J. Antimicrob. Chemother. 68, 977\u2013985 (2013).","journal-title":"J. Antimicrob. Chemother."},{"key":"BFncomms5029_CR32","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1002\/ps.1066","volume":"61","author":"N Fisher","year":"2005","unstructured":"Fisher, N. & Meunier, B. Re-examination of inhibitor resistance conferred by Q(o)-site mutations in cytochrome b using yeast as a model system. Pest Manag. Sci. 61, 973\u2013978 (2005).","journal-title":"Pest Manag. Sci."},{"key":"BFncomms5029_CR33","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1128\/AAC.44.8.2100-2108.2000","volume":"44","author":"M Korsinczky","year":"2000","unstructured":"Korsinczky, M. et al. Mutations in Plasmodium falciparum cytochrome b that are associated with atovaquone resistance are located at a putative drug-binding site. Antimicrob. Agents Chemother. 44, 2100\u20132108 (2000).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFncomms5029_CR34","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/j.1567-1364.2007.00328.x","volume":"8","author":"N Fisher","year":"2008","unstructured":"Fisher, N. & Meunier, B. Molecular basis of resistance to cytochrome bc1 inhibitors. FEMS Yeast Res. 8, 183\u2013192 (2008).","journal-title":"FEMS Yeast Res."},{"key":"BFncomms5029_CR35","doi-asserted-by":"publisher","first-page":"17142","DOI":"10.1074\/jbc.M500388200","volume":"280","author":"JJ Kessl","year":"2005","unstructured":"Kessl, J. J. et al. Cytochrome b mutations that modify the ubiquinol-binding pocket of the cytochrome bc(1) complex and confer anti-malarial drug resistance in Saccharomyces cerevisiae. J. Biol. Chem. 280, 17142\u201317148 (2005).","journal-title":"J. Biol. Chem."},{"key":"BFncomms5029_CR36","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1021\/jm901545z","volume":"53","author":"N Kongkathip","year":"2010","unstructured":"Kongkathip, N. et al. Transforming rhinacanthin analogues from potent anticancer agents into potent antimalarial agents. J. Med. Chem. 53, 1211\u20131221 (2010).","journal-title":"J. Med. Chem."},{"key":"BFncomms5029_CR37","doi-asserted-by":"publisher","first-page":"3151","DOI":"10.1021\/ja01190a001","volume":"70","author":"LF Fieser","year":"1948","unstructured":"Fieser, L. F. et al. Naphthoquinone antimalarials; general survey. J. Am. Chem. Soc. 70, 3151\u20133155 (1948).","journal-title":"J. Am. Chem. Soc."},{"key":"BFncomms5029_CR38","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/BF00744680","volume":"12","author":"BL Trumpower","year":"1980","unstructured":"Trumpower, B. L. & Haggerty, J. G. Inhibition of electron transfer in the cytochrome b-c, segment of the mitochondrial respiratory chain by a synthetic analogue of ubiquinone. J. Bioenerg. Biomembr. 12, 151\u2013164 (1980).","journal-title":"J. Bioenerg. Biomembr."},{"key":"BFncomms5029_CR39","doi-asserted-by":"publisher","first-page":"17542","DOI":"10.1074\/jbc.M710126200","volume":"283","author":"SR Solmaz","year":"2008","unstructured":"Solmaz, S. R. & Hunte, C. Structure of complex III with bound cytochrome c in reduced state and definition of a minimal core interface for electron transfer. J. Biol. Chem. 283, 17542\u201317549 (2008).","journal-title":"J. Biol. Chem."},{"key":"BFncomms5029_CR40","doi-asserted-by":"publisher","first-page":"2800","DOI":"10.1073\/pnas.052704699","volume":"99","author":"C Lange","year":"2002","unstructured":"Lange, C. & Hunte, C. Crystal structure of the yeast cytochrome bc(1) complex with its bound substrate cytochrome c. Proc. Natl Acad. Sci. USA 99, 2800\u20132805 (2002).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFncomms5029_CR41","doi-asserted-by":"publisher","first-page":"e27219","DOI":"10.1371\/journal.pone.0027219","volume":"6","author":"WX Lan","year":"2011","unstructured":"Lan, W. X. et al. Conformational toggling of yeast iso-1-cytochrome c in the oxidized and reduced states. PLoS ONE 6, e27219 (2011).","journal-title":"PLoS ONE"},{"key":"BFncomms5029_CR42","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/0005-2728(83)90083-X","volume":"722","author":"A Tsai","year":"1983","unstructured":"Tsai, A. & Palmer, G. Potentiometric studies on yeast complex III. Biochim. Biophys. Acta 722, 349\u2013363 (1983).","journal-title":"Biochim. Biophys. Acta"},{"key":"BFncomms5029_CR43","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1111\/j.1432-1033.1992.tb17235.x","volume":"208","author":"TA Link","year":"1992","unstructured":"Link, T. A., Hagen, W. R., Pierik, A. J., Assmann, C. & von Jagow, G. Determination of the redox properties of the Rieske [2Fe-2S] cluster of bovine heart bc1 complex by direct electrochemistry of a water-soluble fragment. Eur. J. Biochem. 208, 685\u2013691 (1992).","journal-title":"Eur. J. Biochem."},{"key":"BFncomms5029_CR44","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.jmb.2007.02.013","volume":"368","author":"CRD Lancaster","year":"2007","unstructured":"Lancaster, C. R. D., Hunte, C., Kelley, J., Trumpower, B. L. & Ditchfield, R. A comparison of stigmatellin conformations, free and bound to the photosynthetic reaction center and the cytochrome bc(1) complex. J. Mol. Biol. 368, 197\u2013208 (2007).","journal-title":"J. Mol. Biol."},{"key":"BFncomms5029_CR45","doi-asserted-by":"publisher","first-page":"D130","DOI":"10.1093\/nar\/gkr1079","volume":"40","author":"KD Pruitt","year":"2012","unstructured":"Pruitt, K. D., Tatusova, T., Brown, G. R. & Maglott, D. R. NCBI reference sequences (RefSeq): current status, new features and genome annotation policy. Nucleic Acids Res. 40, D130\u2013D135 (2012).","journal-title":"Nucleic Acids Res."},{"key":"BFncomms5029_CR46","doi-asserted-by":"publisher","first-page":"D161","DOI":"10.1093\/nar\/gkp885","volume":"38","author":"CJ Sigrist","year":"2010","unstructured":"Sigrist, C. J. et al. PROSITE, a protein domain database for functional characterization and annotation. Nucleic Acids Res. 38, D161\u2013D166 (2010).","journal-title":"Nucleic Acids Res."},{"key":"BFncomms5029_CR47","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1186\/1471-2105-11-431","volume":"11","author":"LS Johnson","year":"2010","unstructured":"Johnson, L. S., Eddy, S. R. & Portugaly, E. Hidden Markov model speed heuristic and iterative HMM search procedure. BMC Bioinformatics 11, 431 (2010).","journal-title":"BMC Bioinformatics"},{"key":"BFncomms5029_CR48","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/msb.2011.75","volume":"7","author":"F Sievers","year":"2011","unstructured":"Sievers, F. et al. Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega. Mol. Syst. Biol. 7, 539 (2011).","journal-title":"Mol. Syst. Biol."},{"key":"BFncomms5029_CR49","doi-asserted-by":"publisher","first-page":"3150","DOI":"10.1093\/bioinformatics\/bts565","volume":"28","author":"L Fu","year":"2012","unstructured":"Fu, L., Niu, B., Zhu, Z., Wu, S. & Li, W. CD-HIT: accelerated for clustering the next-generation sequencing data. Bioinformatics 28, 3150\u20133152 (2012).","journal-title":"Bioinformatics"},{"key":"BFncomms5029_CR50","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1093\/jac\/dks504","volume":"68","author":"GL Nixon","year":"2013","unstructured":"Nixon, G. L. et al. Antimalarial pharmacology and therapeutics of atovaquone. J. Antimicrob. Chemother. 68, 977\u2013985 (2013).","journal-title":"J. Antimicrob. Chemother."},{"key":"BFncomms5029_CR51","doi-asserted-by":"publisher","first-page":"3977","DOI":"10.1074\/jbc.M606482200","volume":"282","author":"T Wenz","year":"2007","unstructured":"Wenz, T. et al. Mutational analysis of cytochrome b at the ubiquinol oxidation site of yeast complex III. J. Biol. Chem. 282, 3977\u20133988 (2007).","journal-title":"J. Biol. Chem."},{"key":"BFncomms5029_CR52","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1086\/318835","volume":"183","author":"P Kazanjian","year":"2001","unstructured":"Kazanjian, P. et al. Pneumocystis carinii cytochrome b mutations are associated with atovaquone exposure in patients with AIDS. J. Infect. Dis. 183, 819\u2013822 (2001).","journal-title":"J. Infect. Dis."},{"key":"BFncomms5029_CR53","doi-asserted-by":"publisher","first-page":"2725","DOI":"10.1128\/AAC.47.9.2725-2731.2003","volume":"47","author":"P Hill","year":"2003","unstructured":"Hill, P. et al. Recapitulation in Saccharomyces cerevisiae of cytochrome b mutations conferring resistance to atovaquone in Pneumocystis jirovecii. Antimicrob. Agents Chemother. 47, 2725\u20132731 (2003).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFncomms5029_CR54","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1107\/S0907444909047337","volume":"66","author":"W Kabsch","year":"2010","unstructured":"Kabsch, W. Xds. Acta Crystallogr. D Biol. Crystallogr. 66, 125\u2013132 (2010).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"BFncomms5029_CR55","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1107\/S0907444909052925","volume":"66","author":"PD Adams","year":"2010","unstructured":"Adams, P. D. et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D Biol. Crystallogr. 66, 213\u2013221 (2010).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"BFncomms5029_CR56","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1107\/S0907444910007493","volume":"66","author":"P Emsley","year":"2010","unstructured":"Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. D Biol. Crystallogr. 66, 486\u2013501 (2010).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"BFncomms5029_CR57","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1107\/S0907444904011679","volume":"60","author":"AW Schuttelkopf","year":"2004","unstructured":"Schuttelkopf, A. W. & van Aalten, D. M. PRODRG: a tool for high-throughput crystallography of protein-ligand complexes. Acta Crystallogr. D Biol. Crystallogr. 60, 1355\u20131363 (2004).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"BFncomms5029_CR58","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1107\/S0907444910045749","volume":"67","author":"MD Winn","year":"2011","unstructured":"Winn, M. D. et al. Overview of the CCP4 suite and current developments. Acta Crystallogr. D Biol. Crystallogr. 67, 235\u2013242 (2011).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"BFncomms5029_CR59","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1107\/S0907444903008126","volume":"59","author":"E Potterton","year":"2003","unstructured":"Potterton, E., Briggs, P., Turkenburg, M. & Dodson, E. A graphical user interface to the CCP4 program suite. Acta Crystallogr. D Biol. Crystallogr. 59, 1131\u20131137 (2003).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"BFncomms5029_CR60","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen, E. F. et al. UCSF chimera - A visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605\u20131612 (2004).","journal-title":"J. Comput. Chem."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/ncomms5029.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ncomms5029","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ncomms5029.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T22:44:07Z","timestamp":1672958647000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncomms5029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,4]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2014,9,22]]}},"alternative-id":["BFncomms5029"],"URL":"https:\/\/doi.org\/10.1038\/ncomms5029","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,4]]},"assertion":[{"value":"2 September 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4029"}}